Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
49.89
+0.48 (0.97%)
Jan 23, 2026, 3:00 PM CST
SHA:603334 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 106.02 | 166.78 | 156.74 | 217.73 | 84.48 | 37.86 |
Trading Asset Securities | 0.01 | - | - | 0.83 | 0.18 | 0.86 |
Cash & Short-Term Investments | 106.03 | 166.78 | 156.74 | 218.57 | 84.66 | 38.72 |
Cash Growth | -32.36% | 6.40% | -28.29% | 158.18% | 118.62% | - |
Accounts Receivable | 296.65 | 244.82 | 157.4 | 181.05 | 164.82 | 132.19 |
Other Receivables | 12.15 | 8.18 | 18.59 | 12.21 | 7.45 | 4.73 |
Receivables | 308.8 | 253 | 175.99 | 193.26 | 172.27 | 136.92 |
Inventory | 368.41 | 242.01 | 198.38 | 104.24 | 118.48 | 128.58 |
Other Current Assets | 154.24 | 68.38 | 36.99 | 96.64 | 46.9 | 35.73 |
Total Current Assets | 937.48 | 730.18 | 568.1 | 612.7 | 422.31 | 339.96 |
Property, Plant & Equipment | 424.54 | 433.02 | 405.92 | 254.98 | 115.07 | 78.06 |
Other Intangible Assets | 58.44 | 59.76 | 61.14 | 50.85 | 51.97 | 9.09 |
Long-Term Deferred Tax Assets | 9.98 | 8.86 | 4.71 | 6.06 | 4.21 | 0.78 |
Long-Term Deferred Charges | 1.62 | 2.61 | 3.91 | 4.63 | 3.66 | - |
Other Long-Term Assets | 3.79 | 2.33 | 7.66 | 8.61 | 1.87 | 1 |
Total Assets | 1,436 | 1,237 | 1,051 | 937.82 | 599.09 | 428.9 |
Accounts Payable | 139.14 | 59.86 | 57.42 | 66.02 | 61.24 | 28.27 |
Accrued Expenses | 9.76 | 43.04 | 27.88 | 40.8 | 19.89 | 11.71 |
Short-Term Debt | 259.61 | 173.39 | 141.53 | 159.28 | 100.11 | 58.64 |
Current Portion of Long-Term Debt | 30.61 | 7.29 | 0.28 | 10.11 | - | - |
Current Portion of Leases | - | 3.08 | 3.37 | 5.02 | 0.33 | - |
Current Income Taxes Payable | 13.33 | 3.09 | 0.34 | 3.06 | 2.32 | 1.13 |
Current Unearned Revenue | 10.62 | 27.44 | 30.44 | 35.35 | 20.33 | 27.11 |
Other Current Liabilities | 4.28 | 41.34 | 75.38 | 53.51 | 9 | 18.54 |
Total Current Liabilities | 467.34 | 358.53 | 336.64 | 373.14 | 213.23 | 145.4 |
Long-Term Debt | 80.19 | 106.37 | 72.9 | 40.5 | - | - |
Long-Term Leases | 1.42 | 3.48 | - | 5.14 | - | - |
Long-Term Unearned Revenue | 10.79 | 11.36 | 11.91 | 2.03 | 2.55 | 3.07 |
Long-Term Deferred Tax Liabilities | 1.14 | 1.22 | 0.5 | 1.94 | 0.07 | 0.21 |
Other Long-Term Liabilities | - | - | - | 1.66 | 1 | - |
Total Liabilities | 560.88 | 480.96 | 421.95 | 424.41 | 216.84 | 148.68 |
Common Stock | 107.6 | 107.6 | 107.6 | 107.6 | 105.79 | 105.79 |
Additional Paid-In Capital | 191.59 | - | - | - | 87.29 | 87.29 |
Retained Earnings | 575.78 | 648.19 | 521.9 | 405.82 | 187.69 | 85.78 |
Total Common Equity | 874.97 | 755.79 | 629.5 | 513.42 | 380.77 | 278.86 |
Minority Interest | - | - | - | - | 1.48 | 1.36 |
Shareholders' Equity | 874.97 | 755.79 | 629.5 | 513.42 | 382.25 | 280.22 |
Total Liabilities & Equity | 1,436 | 1,237 | 1,051 | 937.82 | 599.09 | 428.9 |
Total Debt | 371.82 | 293.62 | 218.09 | 220.05 | 100.44 | 58.64 |
Net Cash (Debt) | -265.8 | -126.83 | -61.34 | -1.48 | -15.79 | -19.92 |
Net Cash Per Share | -2.46 | -1.18 | -0.57 | -0.01 | -0.15 | -0.20 |
Filing Date Shares Outstanding | 107.6 | 107.6 | 143.5 | 107.6 | 106.16 | 100 |
Total Common Shares Outstanding | 107.6 | 107.6 | 143.5 | 107.6 | 106.16 | 100 |
Working Capital | 470.14 | 371.64 | 231.46 | 239.56 | 209.08 | 194.56 |
Book Value Per Share | 8.13 | 7.02 | 4.39 | 4.77 | 3.59 | 2.79 |
Tangible Book Value | 816.53 | 696.03 | 568.36 | 462.57 | 328.8 | 269.77 |
Tangible Book Value Per Share | 7.59 | 6.47 | 3.96 | 4.30 | 3.10 | 2.70 |
Buildings | - | 72.03 | 69.95 | 25.06 | 25.61 | 25.61 |
Machinery | - | 128.96 | 122.66 | 103.98 | 92.27 | 59.26 |
Construction In Progress | - | 291.81 | 262.7 | 155.85 | 27.76 | 16.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.